drugset / Trial / NCT00853112
A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension
RandomizedParallel-groupTriple-blindTreatment
Summary
Study will assess PF-00489791 efficacy and safety in Pulmonary Arterial Hypertension (PAH)
Timeline
- Start
- 2009-04
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-00489791 | Small molecule | 1 mg | Oral |
| Subject | PF-00489791 | Small molecule | 2 mg | Oral |
| Subject | PF-00489791 | Small molecule | 4 mg | Oral |
| Subject | PF-00489791 | Small molecule | 10 mg | Oral |
| Subject | PF-00489791 | Small molecule | 20 mg | Oral |
| Comparator | Sildenafil | Unknown | 20 mg | — |